Similar to the effects observed following treatment with Pano, EGCG and I3C downregulate the secretion of IL-10, an immunosuppressive factor in ovarian cancer ascites correlated with proliferation and metastasis, as well as maintenance of the tumorigenic microenvironment [58,59]. Here, IL10 is linked to ovarian cancer.